Autres langues Ocumetics Technology Corp.

Actions

OTC

CA67577H1047

Temps Différé Toronto S.E. Autres places de cotation 19:58:45 14/05/2024			Varia. 5j.	Varia. 1 janv.
0,295 ^CAD	-4,84%		-1,67%	-13,24%

11/04	Ocumetics Technology Corp. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI
2023	Ocumetics Technology Corp. annonce la réussite d'une étude sur les animaux en préparation de sa première étude sur l'homme, qui devrait débuter au premier trimestre 2024 en République dominicaine.	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Ocumetics Technology Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	11/04
Ocumetics Technology Corp (OTC) To Be Featured on Radius Research's Pitch, Deep Dive and Q&A Webinar (Feb 29, 2024)	29/02
Ocumetics Announces Completion of Unit Private Placement	17/01
Ocumetics Technology Corp. announced that it has received CAD 0.4166 million in funding	17/01
Ocumetics Announces Extension of Private Placement	21/12
Ocumetics Announces December 20, 2023 Webinar regarding Successful Completion of Animal Study	15/12
Ocumetics Technology Corp. Announces Successful Completion of Animal Study in Preparation for Its First-In-Human Study, Anticipated to Commence in First Quarter of 2024 in the Dominican Republic	07/12
Ocumetics Announces Successful Completion of Animal Study Q1 2024 First in Human Study Planned	07/12
Ocumetics Technology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	20/11
Ocumetics Announces Private Placement	15/11
Ocumetics Technology Corp. announced that it expects to receive CAD 1 million in funding	15/11
Ocumetics Continues to Meet Significant Development Milestones Lens Design Optimized for Upcoming First in Human Study	18/09/23
Ocumetics Continues to Meet Significant Development Milestones; Lens Design Optimized for Upcoming First in Human Study	18/09/23
Ocumetics Welcomes Dr. Doyle Stulting and Dr. Bart McRoberts to Board of Directors	01/09/23
Ocumetics Technology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	28/08/23
Ocumetics Technology Corp. announced that it has received CAD 1 million in funding	14/08/23
Ocumetics Announces Completion of First Tranche of Unit Private Placement	25/07/23
Ocumetics Announces Private Placement	22/06/23
Ocumetics Technology Corp. announced that it expects to receive CAD 1 million in funding	22/06/23
Ocumetics Announces Commencement of Biocompatibility and Animal Studies for Updated Lens Design	20/06/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Ocumetics Technology Corp.

Actions

OTC

CA67577H1047

Autres langues

Filtres